Emerging research explores how a wearable device may identify infection before symptoms appear, which treatments reduce hospitalizations, and who remains most at risk.
Patients who used statins for at least 4 weeks prior to total hip arthroplasty experienced significantly lower rates of venous thromboembolism within 90 days postoperatively. No significant differences were...
In a retrospective study spanning nearly two decades, researchers found a low incidence of venous thromboembolism following colorectal procedures for pelvic floor and motility disorders, with the highest...
A multicenter study revealed significant variations in the administration of postpartum venous thromboembolism (VTE) prophylaxis and highlighted key risk factors influencing its use.
This COVID-19 roundup includes coverage on the latest estimated number of adults with long COVID, WHO’s updated terminology for pathogens that transmit through the air, how COVID-19 vaccination reduces the...
In this COVID-19 roundup, we discuss the expansion of eligible populations for a COVID-19 booster dose, approval of a nonprescription respiratory infection test, thrombosis risk after COVID-19 infections,...
Patients with inflammatory bowel disease have an increased risk for venous thromboembolism during hospitalization. Researchers in Ontario, Canada, sought to determine whether the risk continues after...
Researchers evaluated data on more than 50,800 participants with rheumatoid arthritis to determine the risk for venous thromboembolism with tofacitinib vs TNF inhibitors.
